This topic contains a solution. Click here to go to the answer

Author Question: Clients enrolled in a clinical drug trial are told that they might receive a placebo drug as part of ... (Read 48 times)

rl

  • Hero Member
  • *****
  • Posts: 579
Clients enrolled in a clinical drug trial are told that they might receive a placebo drug as part of a control group. A client asks the nurse what a placebo is. Which response by the nurse is the most appropriate?
 
  1. A placebo is a substance that has no therapeutic effect.
  2. A placebo is a similar drug that is safe.
  3. A placebo is a drug that has been tested before.
  4. A placebo is an over-the-counter drug.

Question 2

The nurse explains to the client that during the Food and Drug Administration (FDA) drug approval process, clinical investigators from many different medical specialties address concerns. What concerns are addressed?
 
  1. Whether a New Drug Application (NDA) must be filed
  2. The marketability of the drug
  3. What the cost of the drug should be
  4. Whether or not the drug is safe



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ebe

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

Correct Answer: 1
Rationale 1: A placebo is an inert substance that has no therapeutic effect and is used as a control.
Rationale 2: A placebo is not a similar drug
Rationale 3: A placebo is generally not another drug.
Rationale 4: A placebo is not an over-the-counter drug
Global Rationale: A placebo is an inert substance that has no therapeutic effect and is used as a control. A placebo is not a similar drug, generally not another drug, and is not an over-the-counter drug.

Answer to Question 2

Correct Answer: 4
Rationale 1: The pharmaceutical company files the NDA.
Rationale 2: The clinical investigators do not determine marketability of the drug.
Rationale 3: Clinical investigators do not determine the cost of the drug.
Rationale 4: Safety is determined by the FDA during the Investigational New Drug Application process.
Global Rationale: During the FDA drug approval process, clinical investigators address concerns on whether or not the drug is safe. Safety is determined by the FDA during the Investigational New Drug Application process. The pharmaceutical company files the NDA. The clinical investigators do not determine marketability of the drug or determine the cost of the drug.




rl

  • Member
  • Posts: 579
Reply 2 on: Jul 23, 2018
Great answer, keep it coming :)


Animal_Goddess

  • Member
  • Posts: 339
Reply 3 on: Yesterday
Excellent

 

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

Nearly 31 million adults in America have a total cholesterol level that is more than 240 mg per dL.

Did you know?

The term bacteria was devised in the 19th century by German biologist Ferdinand Cohn. He based it on the Greek word "bakterion" meaning a small rod or staff. Cohn is considered to be the father of modern bacteriology.

Did you know?

Carbamazepine can interfere with the results of home pregnancy tests. If you are taking carbamazepine, do not try to test for pregnancy at home.

For a complete list of videos, visit our video library